$DBVT Income Statement | Understand Stock

$DBVT

$10.13 +$0.14 (1.45%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating income
Operating expenses
Research and development expenses
Sales and marketing expenses
General and administrative expenses
Restructuring reversal (expenses)
Total Operating expenses

Loss from operations
Financial income (expense)
Loss before taxes
Income tax
Net loss
Foreign currency translation differences, net of taxes
Actuarial gains on employee benefits, net of taxes
Comprehensive loss
Basic/diluted Net loss per share attributable to shareholders
Weighted average number of shares outstanding used in computing per share amounts:
Basic Net loss per share attributable to shareholders (in USD per share)
Diluted Net loss per share attributable to shareholders (in USD per share)
Weighted average shares outstanding used in computing per share amounts, basic (in shares)
Weighted average shares outstanding used in computing per share amounts, diluted (in shares)

Comments